These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3408331)

  • 1. Quantitative muscle testing in childhood dermatomyositis.
    Miller LC; Michael AF; Baxter TL; Kim Y
    Arch Phys Med Rehabil; 1988 Aug; 69(8):610-3. PubMed ID: 3408331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular strength as an index of response to therapy in childhood dermatomyositis.
    Resnick JS; Mammel M; Mundale MO; Kottke FJ
    Arch Phys Med Rehabil; 1981 Jan; 62(1):12-9. PubMed ID: 7458626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
    Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
    Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
    Naim MY; Reed AM
    J Rheumatol; 2006 Jul; 33(7):1392-4. PubMed ID: 16821273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle strength assessment in polymyositis and dermatomyositis evaluation of the reliability and clinical use of a new, quantitative, easily applicable method.
    Stoll T; Brühlmann P; Stucki G; Seifert B; Michel BA
    J Rheumatol; 1995 Mar; 22(3):473-7. PubMed ID: 7783064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes.
    Guzmán J; Petty RE; Malleson PN
    J Rheumatol; 1994 Apr; 21(4):739-43. PubMed ID: 8035403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.
    Escalante A; Miller L; Beardmore TD
    J Rheumatol; 1993 Aug; 20(8):1340-4. PubMed ID: 8230016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
    Lovell DJ; Lindsley CB; Rennebohm RM; Ballinger SH; Bowyer SL; Giannini EH; Hicks JE; Levinson JE; Mier R; Pachman LM; Passo MH; Perez MD; Reed AM; Schikler KN; Smith M; Zemel LS; Rider LG
    Arthritis Rheum; 1999 Oct; 42(10):2213-9. PubMed ID: 10524696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strength in polymyositis and dermatomyositis: best outcome in patients treated early.
    Fafalak RG; Peterson MG; Kagen LJ
    J Rheumatol; 1994 Apr; 21(4):643-8. PubMed ID: 8035387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis.
    Maillard SM; Jones R; Owens CM; Pilkington C; Woo PM; Wedderburn LR; Murray KJ
    Arthritis Rheum; 2005 Aug; 53(4):558-64. PubMed ID: 16082634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of certain skeletal muscle enzymes in dermatomyositis (a histochemical study)].
    Kop'eva TN; Grushina AG; Zhvaniia MA; Smoliar VSh
    Arkh Patol; 1974; 36(3):46-51. PubMed ID: 4615676
    [No Abstract]   [Full Text] [Related]  

  • 12. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
    McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
    Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive use of hydroxychloroquine in childhood dermatomyositis.
    Olson NY; Lindsley CB
    J Rheumatol; 1989 Dec; 16(12):1545-7. PubMed ID: 2483176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study.
    Apaz MT; Saad-Magalhães C; Pistorio A; Ravelli A; de Oliveira Sato J; Marcantoni MB; Meiorin S; Filocamo G; Pilkington C; Maillard S; Al-Mayouf S; Prahalad S; Fasth A; Joos R; Schikler K; Mozolova D; Landgraf JM; Martini A; Ruperto N;
    Arthritis Rheum; 2009 Apr; 61(4):509-17. PubMed ID: 19333974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A statistical analysis of the loss of muscle strength in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Babbs R; Gilula Z; Karrison T; Meier P
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):123-38. PubMed ID: 7122997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Muscle latency in polymyositis in children].
    Renault F; Raimbault J
    Electrodiagn Ther; 1980; 17(2):87-95. PubMed ID: 7408754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Electromyography in polymyositis in children].
    Renault F; Raimbault J
    Electrodiagn Ther; 1978; 15(4):141-51. PubMed ID: 753599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Staircase phenomenon in children with progressive muscular dystrophy and dermatomyositis].
    Uzunova M; Gatev V; Stomatova L
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1450-4. PubMed ID: 213914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum enzyme, myoglobin and muscle strength relationships in polymyositis and dermatomyositis.
    Kroll M; Otis J; Kagen L
    J Rheumatol; 1986 Apr; 13(2):349-55. PubMed ID: 3723497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dermatomyositis associated with normal serum muscle enzyme levels].
    Buskila D; Keystone E; Sukenik S
    Harefuah; 1989 Apr; 116(8):414-6. PubMed ID: 2744649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.